Frontdoor Inc (FTDR) is slightly overvalued and we do not publish a verdict for Medifast Inc (MED).
We publish an intrinsic value for FTDR but not for MED, so the two cannot be ranked on price.
Values as of the 22 Sept 2026 close.
Discounting its cash flows at 10.7% (average of 3 methods) values the shares at $66.20; the price of $77.19 is 17% above that value, and 71% of that value comes from beyond year five.
Leak Score 59/100 on 3 of 12 signals
We do not publish a value for this company: there is no balance sheet on file to value what it owns.
Leak Score 0/100 on 1 of 12 signals
| Metric | FTDR | MED |
|---|---|---|
| Verdict | Slightly overvalued | Not valued |
| Price | $77.19 | $12.08 |
| Intrinsic value | $66.20 | — |
| Margin of safety | -17% | — |
| Leak Score | 59/100 (3/12) | 0/100 (1/12) |
| Market cap | $5.3B | $135M |
| Revenue growth, 5 years | 7.3% | -16.2% |
| Operating margin | 20.1% | -5.5% |
| Net margin | 12.8% | -8.1% |
| Return on equity | 101.9% | -12.4% |
| Debt to equity | 4.15 | 0.14 |
| P/E | 20.4x | — |
| Forward P/E | 14.9x | — |
| P/B | 18.8x | 0.7x |